NCT07197580
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07197580
Title Study of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC (LUTEON)
Acronym LUTEON
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Telix Pharmaceuticals (Innovations) Pty Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.